Oral News and Research

RSS

Viewpoints: Keeping high court arguments away from TV is 'national shame'

Why the U.S. Supreme Court continues to hold its oral arguments away from television cameras remains a mystery and national shame. The court is about to begin hearing six hours of arguments over three days in a lawsuit brought by more than half of the states in the nation to challenge the constitutionality of the Affordable Care Act, one of the most important pieces of economic legislation passed by Congress since the New Deal.

27 Mar 2012

First Edition: March 27, 2012

In today's headlines, the Supreme Court chronicles continue, with reports detailing what happened during yesterday's opening-day oral arguments and previewing what's on tap for today.

27 Mar 2012

Viewpoints: Walter Dellinger's health care myths; A 'moment of truth' or end of health reform?

Commentators from around the country offer their views of the historic case being heard at the Supreme Court today.

27 Mar 2012

High court hears first day of health law arguments; Justices appear skeptical of jurisdictional question

Early reports provide insights into what went on inside the Court as justices contemplated whether the Anti-Injuction Act would preclude their review of the legal challenges to the individual mandate.

27 Mar 2012

Rivaroxaban safer, effective than standard therapy in treating PE

A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism - a blockage of lung blood vessels usually caused by a clot - and showed comparable efficacy, according to data from the EINSTEIN-PE trial presented today at the American College of Cardiology's 61st Annual Scientific Session.

27 Mar 2012

Ariosa completes clinical validation study for Harmony Prenatal Test

Ariosa Diagnostics (formerly Aria Diagnostics), a molecular diagnostics company, today announced the completion of its clinical validation study for the Harmony Prenatal Test.

26 Mar 2012

Setting the scene: Court arguments offer different kind of drama

With no Twitter, cameras or telephones allowing reports from inside the court, much of the action will take place on the outside. A range of groups have planned demonstrations. All the while, the lawyers involved in the arguments have been busy with "moot court" practice sessions; spectators have been waiting in line in hopes of getting a seat; and stakeholders, such as the health care industry, are anxiously watching for clues to the outcome.

26 Mar 2012

Spectator point-by-point guides to the Supreme Court's health law review

As the health law's challengers and defenders head to court, media outlets take big-picture looks at how the upcoming three days of arguments could play out, provide primers that detail the key aspects of the issues in play as well and give a heads up on what to watch for.

26 Mar 2012

Politics provides the backdrop for justices' consideration of health law

The proceedings at the high court could shake the fall elections in a variety of ways. Even before the arguments begin, both sides of the fight are a bit battleworn from the court's past rulings and the path that has led to this week's clashes.

26 Mar 2012

Theracurmin shows positive impact on human diastolic functions

The research group led by Dr. Koji Hasegawa, Director of the Translational Research Division at the National Hospital Organization Kyoto Medical Center and Dr. Tatsuya Morimoto, Professor at the Molecular Medicine School of Pharmaceutical Sciences, University of Shizuoka, announced today based on the recent human clinical trials, that Theracurmin has continuously shown positive impact on human diastolic functions.

26 Mar 2012

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced positive results from a Phase 2 clinical trial for ETC-1002.

26 Mar 2012

Commensal bacteria may play an important role in influencing and controlling allergic inflammation

When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense. Every human being carries over 100 trillion individual bacterial cells within the intestine -- ten times more cells than comprise the body itself.

26 Mar 2012

First Edition: March 26, 2012

Today marks the beginning of the Supreme Court's three days of oral arguments regarding the health law. Headlines break down the key points of those arguments, as well as the political and historical context in which they will be advanced.

26 Mar 2012

Results from Merck's vorapaxar study on cardiovascular events

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

26 Mar 2012

Periodontal treatment may decrease medical care costs for people with diabetes

Medical costs are lower for people with diabetes who receive treatment for gum disease, according to a study presented today to the American Association for Dental Research by Dr. Marjorie Jeffcoat of the University of Pennsylvania.

26 Mar 2012

Supreme Court watch: Counting down to health law's historic arguments

Two years and three days after President Barack Obama signed into law a health care overhaul aimed at extending medical insurance to more than 30 million Americans, the high court begins three days of hearings over the law's validity. The challenge from 26 states and a small business group puts the court smack in the middle of a heavily partisan fight over the president's major domestic accomplishment and a presidential election campaign in which all his Republican challengers oppose the law.

26 Mar 2012

Medtronic announces results from two Symplicity system trials on treatment-resistant hypertension

Medtronic, Inc., announced that the Symplicity renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment-resistant hypertension, according to data from two clinical trials presented at the 2012 American College of Cardiology (ACC) meeting.

From Medtronic 26 Mar 2012

S. gordonii may trigger infective endocarditis

Oral bacteria that escape into the bloodstream are able to cause blood clots and trigger life-threatening endocarditis. Further research could lead to new drugs to tackle infective heart disease, say scientists presenting their work at the Society for General Microbiology's Spring Conference in Dublin this week.

26 Mar 2012

Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C

Amgen announced today positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced serum low density lipoprotein cholesterol (LDL-C), also known as "bad" cholesterol, by up to 81 percent versus placebo (maximum reduction) in subjects on low to moderate doses of statins/

26 Mar 2012

Periodontal treatment linked with decrease in hospital admissions, medical care costs

Today, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, an abstract titled "Periodontal Therapy Reduces Hospitalizations and Medical Care Costs in Diabetics" to determine if periodontal treatment was associated with the number of hospitalizations and cost of medical care among diabetics with periodontal disease.

26 Mar 2012